CLICLAB TRANSFORMATIVE AGENT SL

Their core work

CLICLAB Transformative Agent is a Barcelona-based SME that appears to provide digital tools and platforms supporting health research, particularly in patient engagement, data collection, and clinical collaboration. Their project portfolio spans digital platforms for rare disease communities, international childhood leukemia research networks, and studies on the interplay between mental health and gastrointestinal disorders. The company likely contributes technology-driven solutions — such as web platforms, data management, or patient-facing digital tools — to large medical research consortia.

What they specialise in

How they've shifted over time

With all three projects starting between 2018 and 2020, CLICLAB's H2020 involvement is concentrated in a narrow window, making it difficult to identify a clear evolution. Their entry point was a digital/ICT-focused rare disease platform (SHARE4RARE, 2018), followed by two health-focused clinical research projects (CLOSER, DISCOvERIE). This suggests a shift from pure digital platform work toward deeper embedding in clinical and translational health research.

CLICLAB appears to be moving from general digital platform development toward specialized digital support for clinical and translational medical research, particularly in mental health and comorbidity studies.

How they like to work

CLICLAB exclusively participates as a partner, never leading as coordinator, and contributes to large consortia — averaging roughly 14 partners per project across 16 countries. With 41 unique partners and no repeated collaborations visible, they operate as a flexible contributor joining diverse teams rather than building a stable core network. This profile suggests a specialist service provider that adapts to consortium needs rather than driving research agendas.

Despite only three projects, CLICLAB has collaborated with 41 unique partners across 16 countries, reflecting participation in large, geographically diverse health research consortia spanning Europe and South America (via the CLOSER project).

What sets them apart

CLICLAB sits at the intersection of digital technology and health research, a combination that is valuable for consortia needing patient-facing platforms, data tools, or digital coordination infrastructure. As a small Barcelona-based SME, they offer agility and focused technical contributions without the overhead of a large institution. Their involvement in both rare diseases and common comorbidities (IBS, depression) shows versatility across different clinical domains.

Highlights from their portfolio

• CLOSER
  Largest funding share (EUR 142,625) and an unusual EU-South America bridging project on childhood leukemia subtypes.
• DISCOvERIE
  Addresses the underexplored gender dimension in brain-gut comorbidities, combining mental health and gastroenterology — a growing research frontier.